{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:30Z","timestamp":1761518790327},"reference-count":97,"publisher":"Informa Healthcare","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1517\/14712598.5.6.817","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T06:22:11Z","timestamp":1118730131000},"page":"817-832","source":"Crossref","is-referenced-by-count":30,"title":["New therapeutic agents for the treatment of bone diseases"],"prefix":"10.1517","volume":"5","author":[{"given":"Allan","family":"Lipton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,6,14]]},"reference":[{"key":"CIT0001","first-page":"133","volume":"79","author":"CHRISTODOULOU C","year":"2003","journal-title":"Med. J."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040316"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200108"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","volume":"18","author":"PFEILSCHIFTER J","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(96)03267-8"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000108746.69256.45"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi122"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","volume":"16","author":"BERENSON JR","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20308"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh141"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68000-7"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64985-3"},{"key":"CIT0026","first-page":"94","author":"RASHID M","year":"1977","journal-title":"Clin. Orthop. Relat. Res."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.3109\/07853899708998743"},{"key":"CIT0028","first-page":"259","volume":"6","author":"SINGER FR","year":"1995","journal-title":"Adv. EndocrinoL Metab."},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2004.00584.x"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011807"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.1.80"},{"key":"CIT0033","unstructured":"NOVARTIS PHARMACEUTICALS CORPORATION: AREDIA\u00ae: [package insert]. Pamidronate disodium prescribing information. East Hanover, NJ, USA (2002)."},{"key":"CIT0034","first-page":"3890","volume":"16","author":"BODY JJ","year":"1998","journal-title":"BURCKHARDT Pet al.: Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J. Clin. Oncol."},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1996.14.1.268","volume":"14","author":"PECHERSTORFER M","year":"1996","journal-title":"Clin. Oncol."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1200\/JCO.2001.19.2.558","volume":"19","author":"MAJOR P","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<6::AID-CNCR3>3.0.CO;2-D"},{"key":"CIT0040","first-page":"59","volume":"7","author":"LIPTON k Treatment of skeletal complications in cancer patients","year":"2004","journal-title":"Oncology Special Edition"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.4.581"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1998.13.11.1668"},{"key":"CIT0047","first-page":"C19\u2013C30","volume":"1423","author":"OLIFF A","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.65.070196.001325"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650101008"},{"key":"CIT0051","first-page":"1127","volume":"50","author":"SELANDER KS","year":"1996","journal-title":"MoL Pharmacol"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00412-4"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1131"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.1993.11.1.59","volume":"11","author":"PATERSON AH","year":"1993","journal-title":"J. Clin. Oncol"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00507.x"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11701"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh243"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2613.2000.00176.x"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1977.tb03354.x"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1042\/cs0780215"},{"key":"CIT0066","first-page":"241","volume":"7","author":"EL SAIVIMAA M","year":"1986","journal-title":"Am. J. Otol"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/0221-8747(81)90046-1"},{"key":"CIT0068","first-page":"513","volume":"106","author":"MILLER PD","year":"1999","journal-title":"Paget's Risedronate\/Etidronate Study Group. Am. j Med."},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070112"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(96)00364-X"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00431-8"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2003.12.011"},{"key":"CIT0078","first-page":"144","volume":"99","author":"CHESNUT CH","year":"1995","journal-title":"ENSRUD KE et al.: Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am. J. Med."},{"key":"CIT0079","first-page":"3","volume":"38","author":"MAZZUOLI GF","year":"1986","journal-title":"GENNARI Get al.: Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int."},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030768"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)90005-1"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","volume":"15","author":"DELMAS PD","year":"1997","journal-title":"Clin. Oncol."},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010845"},{"issue":"169","key":"CIT0092","first-page":"2008\u2013","volume":"2003","author":"SMITH MR","year":"2012","journal-title":"\/ Urol"},{"key":"CIT0098","first-page":"488","volume":"334","author":"BERENSON JR","year":"1996","journal-title":"PORTER Let al.: Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl. J. Med."},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg367"},{"key":"CIT0104","first-page":"1133","volume":"90","author":"BODY JJ","year":"2004","journal-title":"LICHINITZER MRet al.: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled Phase III studies. Br. J. Cancer"},{"key":"CIT0106","first-page":"306","volume":"111","author":"BODY JJ","year":"2004","journal-title":"BELL R et ell.: Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain"},{"key":"CIT0107","first-page":"377","volume":"7","author":"ROSEN LS","year":"2001","journal-title":"Cancer J."},{"key":"CIT0109","first-page":"36","volume":"100","author":"ROSEN LS","year":"2004","journal-title":"DUGAN W JR et al.: Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.116"},{"key":"CIT0113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)40597-0","volume":"141","author":"SMITH JA JR","year":"1989","journal-title":"J. Urol."},{"key":"CIT0114","first-page":"159","volume":"24","author":"ELOMAA I","year":"1992","journal-title":"A controlled study in patients with metastatic prostatic cancer. Int. UroL NephroL"},{"key":"CIT0115","first-page":"939","volume":"76","author":"KYLMALA T","year":"1997","journal-title":"v. and oral clodronate in the relief of bone pain-a double-blind placebo-controlled study in patients with prostate cancer. Br. J. Cancer"},{"key":"CIT0116","first-page":"4717","volume":"17","author":"STRANG P","year":"1997","journal-title":"Anticancer Res."},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.042"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg038"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.97"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.147"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500574"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.19.1458"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11571"},{"key":"CIT0127","unstructured":"NOVARTIS PHARMACEUTICALS CORPORATION: ZOMETA\u00ae: [package insert]. Zoledronic acid injection prescribing information. East Hanover, NJ, USA (2005)."},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00328-8"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.11.003"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.99.132"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.2003.tb00015.x"},{"key":"CIT0133","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2004.08.013"},{"key":"CIT0136","doi-asserted-by":"publisher","DOI":"10.2174\/1381612003400434"},{"key":"CIT0137","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.10.1739"},{"key":"CIT0138","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867"},{"key":"CIT0140","first-page":"1235","volume":"107","author":"ZHANG J","year":"2001","journal-title":"QI Y et ell.: Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J. Clin. Invest."},{"key":"CIT0141","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03257.x"},{"key":"CIT0142","first-page":"4432","volume":"61","author":"MORONY S","year":"2001","journal-title":"Cancer Res."},{"key":"CIT0146","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-944"},{"key":"CIT0147","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1830978100"},{"key":"CIT0148","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000042162.08938.27"},{"key":"CIT0149","first-page":"680","volume":"291","author":"VIERECK V","year":"2002","journal-title":"LAUCK V et ell.: Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem. Biophys. Res. Commun."},{"key":"CIT0150","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-3-319"},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.10.003"},{"key":"CIT0157","doi-asserted-by":"publisher","DOI":"10.1007\/s005200100249"},{"key":"CIT0159","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1200\/JCO.2001.19.14.3434","volume":"19","author":"ALI SM","year":"2001","journal-title":"Clin. Oncol."},{"key":"CIT0160","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.8.2.469"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.5.6.817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:51:10Z","timestamp":1551055870000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.5.6.817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":97,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,11,24]]},"published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1517\/14712598.5.6.817"],"URL":"https:\/\/doi.org\/10.1517\/14712598.5.6.817","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}